These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6454739)

  • 21. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
    Howard JG; Liew FY; Hale C; Nicklin S
    J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
    Scott P; Natovitz P; Sher A
    J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG; Liew FY
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.
    Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
    Korean J Parasitol; 2007 Jun; 45(2):103-9. PubMed ID: 17570972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.
    Hill JO
    Immunology; 1991 Feb; 72(2):282-6. PubMed ID: 1826673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.
    Yang DM; Rogers MV; Liew FY
    Immunology; 1991 Jan; 72(1):3-9. PubMed ID: 1997399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice.
    Howard JG; Hale C; Chan-Liew WL
    Parasite Immunol; 1980; 2(4):303-14. PubMed ID: 7220075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cell-mediated immunity in cutaneous leishmaniasis.
    Liew FY
    Immunol Lett; 1987 Dec; 16(3-4):321-7. PubMed ID: 2895065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
    Mitchell GF; Handman E
    Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):11-25. PubMed ID: 6870673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host and parasite factors influencing the expression of cutaneous leishmaniasis.
    Sher A; Sacks DL; Scott PA
    Ciba Found Symp; 1983; 99():174-89. PubMed ID: 6227463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.
    Nasseri M; Modabber FZ
    Infect Immun; 1979 Nov; 26(2):611-4. PubMed ID: 546790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental cutaneous leishmaniasis. I. Nonspecific immunodepression in BALB/c mice infected with Leishmania tropica.
    Scott PA; Farrell JP
    J Immunol; 1981 Dec; 127(6):2395-400. PubMed ID: 6457874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.
    Basak SK; Saha B; Bhattacharya A; Roy S
    Eur J Immunol; 1992 Aug; 22(8):2041-5. PubMed ID: 1386313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.